fomivirsen sodium
Trade name: vitravene
Small moleculeapproved
Approved
Aug 26, 1998
Fomivirsen is an antisense antiviral drug that was used in the treatment of cytomegalovirus retinitis (CMV) in immunocompromised patients, including those with AIDS. It was administered via intraocular injection. — Wikipedia
Clinical trial activity
4 trials · 1 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00002187)
Timeline
1990s
- Aug 26, 1998
Ionis Pharmaceuticals, Inc. — Earliest FDA Approval
- Aug 26, 1998
Ionis Pharmaceuticals, Inc. — NDA Organization
- Aug 26, 1998
Novartis — NDA Secondary Org
- Jan 1, 1999
Ionis Pharmaceuticals, Inc. — Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Major intermediate early region 2 mRNAANTISENSE INHIBITOR
Major intermediate early region 2 mRNA antisense inhibitor
Antisense therapy; It's a phosphorothioate oligonucleotide
Approval history
- approvedPriority reviewAug 26, 1998
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaFomivirsen ↗
- NCATSQX5LK7YCHV ↗
- ChEMBLCHEMBL1201688 ↗
- ChEMBLCHEMBL1201512 ↗
Also known as
- fomivirisen
- fomivirisen
- fomivirsen
- fomivirsen
- fomivirsen
- fomivirsen
- fomivirsen
- fomivirsen sodium
- fomivirsen sodium
- fomivirsen sodium
- fomivirsen sodium
- fomivirsen sodium
- fomivirsen sodium
- fomivirsen sodium
- isis 2922
- isis-2922
- isis-2922
- isis-2922
- vitravene
- vitravene
- vitravene
- vitravene
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00002156 | Phase 2 | Nov 2, 1999 | Ionis Pharmaceuticals, Inc. |
| NCT00002187 | N/A | Nov 2, 1999 | Ionis Pharmaceuticals, Inc. |
| NCT00002355 | N/A | Nov 2, 1999 | Ionis Pharmaceuticals, Inc. |
| NCT00002356 | Phase 2 | Nov 2, 1999 | Ionis Pharmaceuticals, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | For profit | 4 | 4 | 2 | 1999 |
1 organizations
Page 1 / 1
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | For profit | NDA | Aug 26, 1998 |
| Novartis | For profit | NDA2 | Aug 26, 1998 |